Objectives To review the available data about focal primary partial prostate irradiation (focal radiotherapy, FRT) for early prostate cancer. Methods Inclusion criteria: Medline search for English language full paper on primary FRT for early prostate cancer including review articles, planning studies or patient series (clinical outcome available) published before May 31, 2015. Results 22 papers have been found: 11 review articles, 4 planning studies and 7 patient series. Eleven review articles were dedicated to all types of focal therapy including FRT and 2 to FRT only. All planning studies included brachytherapy and showed excellent organ-at-risk sparing. Patient series included together 715 patients (99% treated with brachytherapy) and showed promising tumour control in low-risk cancer. In intermediate-risk tumours, FRT might be suboptimal. Conclusions Primary FRT is feasible in early prostate cancer. As any other focal therapy, FRT remains investigational until numerous questions are answered.
Primary focal prostate radiotherapy: Do all patients really need whole-prostate irradiation? / B.A. Jereczek-Fossa, D. Ciardo, G. Petralia, M. Bellomi, B. De Bari, O. De Cobelli, R. Orecchia. - In: CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY. - ISSN 1879-0461. - 105(2016 Jun 17), pp. 100-111. [10.1016/j.critrevonc.2016.06.010]
Primary focal prostate radiotherapy: Do all patients really need whole-prostate irradiation?
B.A. Jereczek-FossaPrimo
;G. Petralia;M. Bellomi;O. De CobelliPenultimo
;R. OrecchiaUltimo
2016
Abstract
Objectives To review the available data about focal primary partial prostate irradiation (focal radiotherapy, FRT) for early prostate cancer. Methods Inclusion criteria: Medline search for English language full paper on primary FRT for early prostate cancer including review articles, planning studies or patient series (clinical outcome available) published before May 31, 2015. Results 22 papers have been found: 11 review articles, 4 planning studies and 7 patient series. Eleven review articles were dedicated to all types of focal therapy including FRT and 2 to FRT only. All planning studies included brachytherapy and showed excellent organ-at-risk sparing. Patient series included together 715 patients (99% treated with brachytherapy) and showed promising tumour control in low-risk cancer. In intermediate-risk tumours, FRT might be suboptimal. Conclusions Primary FRT is feasible in early prostate cancer. As any other focal therapy, FRT remains investigational until numerous questions are answered.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S1040842816301433-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
607.95 kB
Formato
Adobe PDF
|
607.95 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.